hotspot -WSS

hotspot

author：explore 2025-10-01 18:07:57 - browse：3776

Light micrograph of a fatty liver — Large vacuoles of triglyceride fat, accumulated inside liver cells. Adobe

SAN DIEGO — An experimental obesity drug from Eli Lilly significantly reduced liver fat in a small analysis, supporting further studies of the treatment against nonalcoholic fatty liver disease, an increasingly common condition that lacks approved treatments.

Among 98 patients with nonalcoholic fatty liver disease, those on the highest dose tested of the drug, retatrutide, experienced an 86% decrease in liver fat over 48 weeks, with most of the reduction occurring early on in treatment, according to data presented here at the American Diabetes Association conference Monday.

Additionally, 93% of people on the highest dose achieved resolution of fatty liver disease, defined as having 5% or less liver fat.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Guidelines to prevent youth baseball injuries need more muscle
Next article： Oprah kicked off a national conversation on obesity. Let's have it

Wikipedia

WSS

Adam's Biotech Scorecard: A closer look at Viking Therapeutics, PDS Biotech

Abortion pill Supreme Court ruling could impact entire drug industry

DOJ, FTC to increase scrutiny of all types of health care mergers

Plane’s emergency slide plummets from sky, hits Chicago home

The kidney, in all its complexity, is captured in a new atlas

India sets sights on home

focus

hotspot

focus

ChatGPT in medicine: STAT answers readers' burning questions

New warning issued for rebooking air travel after delays, cancellations

Drug repurposing or repositioning? The language matters

Vertex Pharmaceuticals may move headquarters in Boston

Activists slam private health insurers over coverage restrictions

Stanford president to resign after investigation of research

Trump demands the U.S. pay no more for drugs than other countries … again

Actors' union, Hollywood studios squabble over which side to blame as strike enters 5th day

Drug repurposing or repositioning? The language matters

Readout Newsletter: Blackstone Life Sciences, Merck, Bluebird Bio

Wikipedia

Study says nonprofit hospitals fall short in charity care spending

Russia strikes Ukraine's critical port facilities in Odesa after halting grain deal

Merck drug for rare lung condition set for approval in U.S.

Steward Health Care has deal to sell doctor network to UnitedHealth

Vertex Pharmaceuticals may move headquarters in Boston

Readout Newsletter: Cardior, Regeneron, Nuvation, Dyne and more

entertainment

knowledge

Wikipedia

knowledge